Appendix - ACS Symposium Series (ACS Publications)

Oct 15, 2015 - Note: In lieu of an abstract, this is the chapter's first page. Click to increase image size Free first page. View: Full Text HTML | Hi...
1 downloads 0 Views 171KB Size
Appendix Downloaded by UNIV OF CALIFORNIA SAN DIEGO on February 3, 2016 | http://pubs.acs.org Publication Date (Web): October 15, 2015 | doi: 10.1021/bk-2015-1201.ot002

Table 1. Acronyms 1-D

1-dimensional

2-AA

2-aminobenzoic acid

2-AB

2-aminobenzamide

2-D

2-dimensional

3-OH-Kyn

3-hydroxykynurenine

5-OH-Trp

5-hydroxyl-tryptophan

AAA

amino acid analysis

AAPH

2,2′-azobis(2-amidinopropane) dihydrochloride

AARS

aminoacyl-tRNA synthetases

ABS

Athrobacter ureafaciens sialidase

ABTS

2,2′-azinobis[3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt

ADA

anti-drug antibodies

ADC

antibody–drug conjugate

ADCC

antibody-dependent cellular cytotoxicity

ADCC

antibody-dependent, cell-mediated cytotoxicity

AFFFF

asymmetric flow field-flow fractionation

APTS

9-aminopyrene-1,4,6-trisulfonic acid

Asu

succinimide

ATR

attenuated total reflection

ATR-FTIR

attenuated total reflection-Fourier transform infrared

AUC

area under the curve

AUC

analytical ultracentrifugation

BCA

bicinchoninic acid assay

BKF

bovine kidney fucosidase

BLA

Biologics License Application

bp

base pairs Continued on next page.

© 2015 American Chemical Society

Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb C ACS Symposium Series; American Chemical Society: Washington, DC, 2015.

Downloaded by UNIV OF CALIFORNIA SAN DIEGO on February 3, 2016 | http://pubs.acs.org Publication Date (Web): October 15, 2015 | doi: 10.1021/bk-2015-1201.ot002

Table 1. (Continued). Acronyms BSA

bovine serum albumin

BTG

bovine testes β-galactosidase

C of A

Certificate of Analysis

CaCl2

calcium chloride

CBG

green coffee bean α-galactosidase

CCD

charge-coupled device

CD

circular dichroism

CDC

complement-dependent cytotoxicity

cDNA

complementary DNA

CDR

complementarity-determining regions

CE

capillary electrophoresis

CEX

cation exchange

CEX

cation exchange chromatography

CFG

Consortium for Functional Glycomics

CG-MALS

composition gradient-multi-angle light scattering

CH1

first constant domain of the heavy chain

CH2

second constant domains of the heavy chain

CH3

third constant domains of the heavy chain

CHO

Chinese hamster ovary

CIC

cross-interaction chromatography

CID

collision-induced dissociation

cIEF

capillary isoelectric focusing

CpB

carboxypeptidase B

CpG

cytosine-guanosine dinucleotide

CQA

critical quality attribute

cSDS

capillary sodium dodecylsulfate electrophoresis

cyno

cynomolgus

CZE

capillary zone electrophoresis

DAD

diode array detector

DDA

data-dependent acquisition

DHFR

dihydrofolate reductase

DIA

Data Independent Analysis

DIGE

difference gel electrophoresis Continued on next page.

406

Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb C ACS Symposium Series; American Chemical Society: Washington, DC, 2015.

Downloaded by UNIV OF CALIFORNIA SAN DIEGO on February 3, 2016 | http://pubs.acs.org Publication Date (Web): October 15, 2015 | doi: 10.1021/bk-2015-1201.ot002

Table 1. (Continued). Acronyms diH2O

deionized water

DiOia

dioxindolylalanine diastereomers

DLS

dynamic light scattering

DMSO

dimethylsulfoxide

DOE

design of experiment

DPBS

14190-DPBS obtained from Life Technologies

DPBS

Dulbecco’s phosphate-buffered saline

DSC

differential scanning calorimetry

DSF

differential scanning fluorimetry

DTT

dithiothreitol

E. coli

Escherichia coli

EDTA

ethylenediaminetetraacetic acid

EI

electron impact

EIC

extracted ion chromatograms

EI-GC-MS

electron impact-gas chromatography-mass spectrometry

ELISA

enzyme-linked immunosorbent assay

ELSD

evaporating light scattering detector

EMEA

European Medicines Agency

ESI

electrospray ionization

ESZ

electrical sensing zone

ETD

electron transfer dissociation

ETS

error tolerant search

FA

formic acid

FAB

fast atom bombardment

FcRn

neonatal Fc receptor

FDA

Food and Drug Administration

FDA

U.S. Food and Drug Administration

FFF

field-flow fractionation

FI

flow imaging

FLD

fluorescence detection

FP

fusion protein

FQ

3-(2-furoyl)quinoline-2-carboxaldehyde

FR

fraction rate Continued on next page.

407

Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb C ACS Symposium Series; American Chemical Society: Washington, DC, 2015.

Downloaded by UNIV OF CALIFORNIA SAN DIEGO on February 3, 2016 | http://pubs.acs.org Publication Date (Web): October 15, 2015 | doi: 10.1021/bk-2015-1201.ot002

Table 1. (Continued). Acronyms FRET

fluorescence resonance energy transfer

FTICR

Fourier transform ion cyclotron resonance

FTIR

Fourier-transform infrared spectroscopy

FTIR

Fourier transform infrared

FTN

flow through needle

GlcNAc

N-acetyl-glucosamine

GMP

good manufacturing practice

GS

glutamine synthetase

GU

glucose unit

GUH

Streptococcus pneumoniae hexosaminidase

H

heavy

H

heavy chain

HC

heavy chain

HCD

higher energy collision dissociation

HCD

higher energy collisional dissociation

HCID

higher energy collision-induced dissociation

HCl

hydrochloric acid

HCP

host cell protein

HDX

hydrogen-deuterium exchange

HESI

heated electrospray ionization source

hG-CSF

human granulocyte colony stimulating factor

HIC

hydrophobic interaction chromatography

HILIC

hydrophilic interaction liquid chromatography

HMWS

higher molecular weight species

HOS

higher order structure

HPLC

high-performance liquid chromatography

HPLC

high-pressure liquid chromatography

HRP

horseradish peroxidase

HRP II

histidine-rich protein II

HsTIM

homodimeric triosephosphate isomerase

HTP

High Throughput

IAA

iodoacetic acid

IAM

iodoacetamide Continued on next page.

408

Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb C ACS Symposium Series; American Chemical Society: Washington, DC, 2015.

Downloaded by UNIV OF CALIFORNIA SAN DIEGO on February 3, 2016 | http://pubs.acs.org Publication Date (Web): October 15, 2015 | doi: 10.1021/bk-2015-1201.ot002

Table 1. (Continued). Acronyms ICH

International Conference on Harmonisation

ICIEF

imaged capillary isoelectric focusing

ICP-MS

inductively coupled plasma-mass spectrometry

ID

interior diameter

IEC

ion exchange chromatography

IEF

isoelectric focusing

IEX

ion exchange chromatography

IM-MS

ion mobility mass spectrometry

IRMPD

infrared multiphoton dissociation

iso-Asp

iso-aspartic acid

IUPAC

International Union of Pure and Applied Chemistry

KCN

potassium cyanide

Kyn

kynurenine

L

light

L

light chain

LC

liquid chromatography

LC

light chain

LC-MS

liquid chromatography-mass spectrometry

LC-MS/MS

liquid chromatography-tandem mass spectrometry

LC-UV-MS

liquid chromatography-UV-mass spectrometry

LED

light-emitting diode

LIF

laser-induced fluorescence

LLOQ

lower limit of quantitation

LO

light obscuration

LS

light scattering

LTQ

linear trap quadrupole

Lys-C

lysyl endopeptidase

mAb

monoclonal antibody

MALDI

matrix-assisted laser desorption ionization

MALDI-TOF

matrix assisted laser desorption/ionization-time of flight

MALS

multi-angle light scattering

MC

methylcellulose

MCAE

membrane-confined analytical electrophoresis Continued on next page.

409

Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb C ACS Symposium Series; American Chemical Society: Washington, DC, 2015.

Downloaded by UNIV OF CALIFORNIA SAN DIEGO on February 3, 2016 | http://pubs.acs.org Publication Date (Web): October 15, 2015 | doi: 10.1021/bk-2015-1201.ot002

Table 1. (Continued). Acronyms MCE

microchip electrophoresis

MCE

membrane-confined electrophoresis

MCE-SSE

membrane-confined electrophoresis-steady-state electrophoresis

MCT

mercury cadmium telluride

MPA

mobile phase A

MPB

mobile phase B

MRE

mean residue ellipticity

MRM

multiple reaction monitoring

MS

mass spectrometry

MS/MS

tandem mass spectrometry

MS2

tandem mass spectrometry

MSn

sequential mass spectrometry

MSX

methionine sulfoximine

MTX

methotraxate

MW

molecular weight

MWCO

molecular weight cutoff

MWD

multiple wavelength detector

NA

not available

NaCNBH3

sodium cyanoborohydride

NaOH

sodium hydroxide

NCE

normalized collision energy

ND

not detected

NEM

N-ethylmaleimide

Neu5GC

N-glycolylneuraminic acid

NFK

N-formylkynurenine

NGH

non-glycosylated heavy chain

NGS

next-generation sequencing

NIBRT

National Institute for Bioprocessing Research and Training

NIST

National Institute of Standards and Technology

Nle

norleucine

NMR

nuclear magnetic resonance spectroscopy

NR

nonreducing

NS0

Murine Myeloma Continued on next page.

410

Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb C ACS Symposium Series; American Chemical Society: Washington, DC, 2015.

Downloaded by UNIV OF CALIFORNIA SAN DIEGO on February 3, 2016 | http://pubs.acs.org Publication Date (Web): October 15, 2015 | doi: 10.1021/bk-2015-1201.ot002

Table 1. (Continued). Acronyms NSI-MS

MS nano-infusion mode

NTA

nanoparticle tracking analysis

Nva

norvaline

Oia

oxindolylalanine diastereomomers

OP

operational parameter

p/v

peak-to-valley

PAGE

polyacrylamide gel electrophoresis

PBS

phosphate-buffered saline

PCQA

potential critical quality attribute

PCR

polymerase chain reaction

PCS

photon correlation spectroscopy

Pd

polydispersity

PDA

photodiode array

PENNYK peptide

GFYPSDIAVEWESNGQPENNYK

pI

isoelectric point

PIMT

protein L-isoaspartyl methyltransferace

PNGase F

peptide N-glycosidase F

poly IgG

polyclonal IgG

PPG 2700

poly(propylene glycol) 2700

pQ

pyroglutamic acid

pre-mRNA

primary transcript messenger RNA

PRI

process-related impurity

PSL

polystyrene latex

PTM

post-translational modification

pyro-Glu

N-terminal pyroglutamate

QbD

quality by design

QC

quality control

QELS

quasi-elastic light scattering

qPCR

quantitative polymerase chain reaction

QTOF

quadrupole time-of-flight

qTOF

quantitative time-of-flight

R

correlation coefficient Continued on next page.

411

Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb C ACS Symposium Series; American Chemical Society: Washington, DC, 2015.

Downloaded by UNIV OF CALIFORNIA SAN DIEGO on February 3, 2016 | http://pubs.acs.org Publication Date (Web): October 15, 2015 | doi: 10.1021/bk-2015-1201.ot002

Table 1. (Continued). Acronyms R

reducing

RA

relative abundance

RM

reference material

RMM

resonance mass measurement

RMSD

root-mean-square deviation

RP

reversed phase

RP-HPLC

reversed-phase-high-performance liquid chromatography

RPM

revolutions per minute

RSD

relative standard deviation

S/N

signal to noise

scFc

single chain Fc

SD

standard deviation

SDS

Sequence Detection System

SDS

sodium dodecyl sulfate

SDS-PAGE

sodium dodecyl sulfate-polyacrylamide gel electrophoresis

SE-AUC

sedimentation equilibrium-analytical ultracentrifugation

SEC

size exclusion chromatography

SEC-MALS

size exclusion chromatography-multi-angle light scattering

SIC

self-interaction chromatography

SINE

short interspersed repetitive elements

SLS

static light scattering

SNP

single-nucleotide polymorphism

SOP

standard operating procedure

SRDP

size-related degradation product

Sv

svedberg unit

SV

sequence variant

SVA

sequence variant analysis

SV-AUC

sedimentation velocity-analytical ultracentrifugation

TAMRA.SE

5-carboxytetra-methylrhodamine succinimidyl ester

t-BHP

tert-butyl hydroperoxide

TCEP

tris(2-carboxyethyl)phosphine

TETA

triethylenetetramine

TFA

trifluoroacetic acid Continued on next page.

412

Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb C ACS Symposium Series; American Chemical Society: Washington, DC, 2015.

Downloaded by UNIV OF CALIFORNIA SAN DIEGO on February 3, 2016 | http://pubs.acs.org Publication Date (Web): October 15, 2015 | doi: 10.1021/bk-2015-1201.ot002

Table 1. (Continued). Acronyms TMB

3,3′,5,5′-tetramethylbenzidine

TOF

time-of-flight

TPP

target product profile

TRamp

temperature ramp

Tris

tris(hydroxymethyl)aminomethane

Tris

tris(hydroxymethyl)aminomethane/tris(hydroxymethyl)aminomethane HCl

tRNA

transfer RNA

TUV

tunable ultraviolet

UHPLC

ultrahigh-pressure liquid chromatography

UHPLC

ultra-high-performance liquid chromatography

UHR-ESIQTOF MS

ultrahigh-resolution-electrospray ionization-quadrupole time-of-flight mass spectrometry

UPLC

ultra performance liquid chromatography

USP

United States Pharmacopeia

VH

variable heavy

VWD

variable wavelength detector

WAX

weak anion exchange

WHO

World Health Organization

XIC

extracted ion chromatogram

413

Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb C ACS Symposium Series; American Chemical Society: Washington, DC, 2015.